SANA

Sana Biotechnology, Inc. is an innovative biotechnology firm based in Seattle, Washington, specializing in engineered cell therapies aimed at addressing significant unmet medical needs across diverse disease categories. Leveraging its state-of-the-art cell-engineering platform, the company is at the forefront of advancements in gene therapy and regenerative medicine, striving to redefine therapeutic paradigms and enhance patient outcomes. With a promising pipeline backed by robust research and development efforts, Sana presents a compelling investment opportunity for institutional investors seeking to engage in transformative biotherapeutic innovations.